PROGENITEC, INC.

Medtech · Private

Optical imaging sensor for real-time detection of wound pH and bacterial presence to monitor chronic wound healing status

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$2.5M
Federal grants
$2.5M
4 awards · 2016–2018
Rank in peer group#449 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
2 pending · first 2022
Rank in peer group#237 of 538

Capital timeline

201620172018FEDERAL ↑EQUITY ↓Cumulative $2.5M$597K$654K$582K$688K
201620172018FEDERAL ↑EQUITY ↓Cumulative $2.5M$597K$654K$582K$688K

Latest events

  • Federal grantHealth and Human S · Phase II · A novel optical imaging probe system for assessing wound healing and infection$688K
  • Federal grantHealth and Human S · Phase II · A novel optical imaging probe system for assessing wound healing and infection$582K
  • Federal grantHealth and Human S · Phase II · Development Of Ratiometric Imaging Probe System For Monitoring Inflammation$654K
  • Federal grantHealth and Human S · Phase II · Development Of Ratiometric Imaging Probe System For Monitoring Inflammation$597K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#237 · top 44%
  • Linked publications#43 · top 8%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 3

Recent research by its founders

  • PDL1 Monoclonal Antibody-Modified mPEG–PLGA-NH<sub>2</sub> Nanocomposite Loaded with Heterophyllin B for the Treatment of Gastric Cancer20252 cites
  • A Novel Narrow Bandgap Ru-Doped Sonosensitive Nanosystem with Mitochondrial Targeting/Ultrasound-Responsive CO Release for Tumor Therapy20251 cites
  • Deciphering mechanisms of stress-induced metabolic shifts in Corynebacterium glutamicum by transcriptomics and contextualised modelling20251 cites
  • Omega Ophthalmics LLCSimilar federal contract value in Medtech · null in contracts
  • PRANIONS, INC.Similar federal contract value in Medtech · null in contracts
  • PROPRIO, INCSimilar federal contract value in Medtech · null in contracts
  • Litmus Health, Inc.Similar federal contract value in Medtech · null in contracts
  • DECISIV INTERVENTIONS, LLCSimilar federal contract value in Medtech · null in contracts
  • Promaxo, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .